Latest Financial Performance Reports News

Australian Unity Limited (ASX:AYU) posted a statutory loss of $155.2 million for FY2026, reflecting regulatory headwinds, transformation costs, and sector disruptions, while advancing its climate risk management and strategic portfolio adjustments.

CVC Limited posted a net profit after tax of $7.7 million for FY2026, underpinned by a $37.8 million profit from the Laverton sale and a $13.3 million impairment from the Liverpool project. The company paid a special dividend and restructured leadership amid ongoing capital management efforts.

Rural Funds Group (ASX: RFF) posted a sharp jump in FY26 earnings to $124.1 million, driven by strategic asset sales and property revaluations, while gearing was trimmed to 31.8%. The group maintains steady AFFO and distribution forecasts for FY27 amid ongoing development and sustainability initiatives.

Light & Wonder, Inc. reported robust full-year 2025 financial results, highlighted by record revenues, strong cash flow growth, and a major litigation settlement. The company also completed its transition to a sole ASX listing and returned $877 million to shareholders through share repurchases.

Knosys Limited reported robust Q1 FY26 results with $3.5 million in cash receipts and a steady $9.5 million annual recurring revenue, while advancing its AI-driven Libero X product and appointing a new Chair.

OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.

SomnoMed reports a strong start to FY26 with 13.5% revenue growth and confirms the Clayton Sleep Institute as the first US site for its pivotal Rest Assure clinical study, backed by FDA protocol agreement.

BetMakers Technology Group has reported a remarkable 361% growth in adjusted EBITDA for Q1 FY26, driven by strong revenue gains and operational efficiencies, while advancing its strategic expansion into the Las Vegas racing market.

Mitchell Services Limited delivered a robust Q1 FY26 performance, marked by a 68% jump in EBITDA and a dramatic 93% reduction in net debt. The company’s strategic investment in a decarbonisation joint venture signals a forward-looking growth trajectory.

Mayne Pharma Group Limited reported a robust FY25 with a 5% revenue increase to A$408.1 million and a 105% surge in underlying EBITDA, driven by strong growth in Women’s Health and strategic acquisitions in Dermatology.

McMillan Shakespeare Limited reported steady FY25 growth with Normalised UNPATA of $103.2 million and an 8.3% dividend yield, underpinned by digital innovation and strategic investments.

Airtasker Limited reported a robust FY25 with double-digit revenue growth and positive free cash flow, underpinned by strong Australian performance and rapid expansion in the UK and US markets.